ALTEN: A High‐Fidelity Primary Tissue‐Engineering Platform to Assess Cellular Responses Ex Vivo
Authors:
Open Access
- 25 May 2022
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 9 (21) , e2103332
Abstract
To fully investigate cellular responses to stimuli and perturbations within tissues, it is essential to replicate the complex molecular interactions within the local microenvironment of cellular niches. Here, the authors introduce Alginate‐based tissue engineering (ALTEN), a biomimetic tissue platform that allows ex vivo analysis of explanted tissue biopsies. This method preserves the original characteristics of the source tissue's cellular milieu, allowing multiple and diverse cell types to be maintained over an extended period of time. As a result, ALTEN enables rapid and faithful characterization of perturbations across specific cell types within a tissue. Importantly, using single‐cell genomics, this approach provides integrated cellular responses at the resolution of individual cells. ALTEN is a powerful tool for the analysis of cellular responses upon exposure to cytotoxic agents and immunomodulators. Additionally, ALTEN's scalability using automated microfluidic devices for tissue encapsulation and subsequent transport, to enable centralized high‐throughput analysis of samples gathered by large‐scale multicenter studies, is shown.Keywords
Funding Information
- Cancer Council NSW (RG18‐03)
- National Breast Cancer Foundation (IIRS‐21‐096)
- American Cancer Society (124571‐RSG‐13‐297‐01)
- National Health and Medical Research Council (GNT1145319, GNT2012941, GNT1184809, GNT1158590)
- Cancer Institute NSW (CDF181218)
This publication has 60 references indexed in Scilit:
- Alginate-Based Biomaterials for Regenerative Medicine ApplicationsMaterials, 2013
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- An expression atlas of human primary cells: inference of gene function from coexpression networksBMC Genomics, 2013
- Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15Journal of Clinical Investigation, 2012
- Intra-tumour heterogeneity: a looking glass for cancer?Nature Reviews Cancer, 2012
- Hydrogels as extracellular matrix mimics for 3D cell cultureBiotechnology and Bioengineering, 2009
- The Immunological Genome Project: networks of gene expression in immune cellsNature Immunology, 2008
- Serine protease HtrA1 modulates chemotherapy-induced cytotoxicityJournal of Clinical Investigation, 2006
- Identification of Genes with Differential Expression in Acquired Drug-Resistant Gastric Cancer Cells Using High-Density Oligonucleotide MicroarraysClinical Cancer Research, 2004
- Cystatin M suppresses the malignant phenotype of human MDA-MB-435S cellsOncogene, 2003